PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Forward Dividend Yield % : 0.00% (As of May. 30, 2024)

View and export this data going back to 2021. Start your Free Trial

What is PT Diagnos Laboratorium Utama Tbk Forward Dividend Yield %?

As of today (2024-05-30), the Forward Annual Dividend Yield of PT Diagnos Laboratorium Utama Tbk is 0.00%.

As of today (2024-05-30), the Trailing Annual Dividend Yield of PT Diagnos Laboratorium Utama Tbk is 0.00%.

ISX:DGNS's Forward Dividend Yield % is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 1.54
* Ranked among companies with meaningful Forward Dividend Yield % only.

PT Diagnos Laboratorium Utama Tbk's Dividends per Share for the six months ended in . 20 was Rp0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield %

For the Diagnostics & Research subindustry, PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield % falls into.

PT Diagnos Laboratorium Utama Tbk Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

PT Diagnos Laboratorium Utama Tbk Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of PT Diagnos Laboratorium Utama Tbk's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PT Diagnos Laboratorium Utama Tbk (ISX:DGNS) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Teuku Cik Ditiro 1 No. 11 A, B, C, Gedung Graha Anam, 2nd Floor, Kelurahan Gondangdia, Kecamatan Menteng, Jakarta Pusat, Jakarta, IDN, 10350

Website

https://www.diagnos.co.id

PT Main Laboratory Diagnos Tbk provides laboratory services that includes health support service activities that are managed by both the government and the private sector, such as health laboratories. The company's products and services include Service Home Service, Corporate Service, Clinical Laboratory, Genomics Laboratory, Inspection Package, Homecare Diagnos, and Examination Panel.